ANORO ELLIPTA is a prescription medication designed for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is not intended for the relief of acute bronchospasm or for the treatment of asthma. ANORO ELLIPTA is a combination inhaler that contains two active ingredients: umeclidinium, a long-acting muscarinic antagonist (LAMA), and vilanterol, a long-acting beta2-adrenergic agonist (LABA). These components work together to relax the muscles around the airways in the lungs, making it easier to breathe. The medication is administered once daily using a specific dry powder inhaler device known as ELLIPTA. It is important for patients to use ANORO ELLIPTA regularly to achieve optimal benefits, and it should be used strictly according to a healthcare provider's instructions.
When using ANORO ELLIPTA, a medication prescribed for chronic obstructive pulmonary disease (COPD), it's crucial to adhere strictly to your doctor's instructions and thoroughly read the label that accompanies the medicine. This ensures you understand the correct usage and can identify any potential side effects. Common side effects may include sore throat, sinusitis, or headache. Although rare, more serious side effects like rapid heart rate, high blood pressure, or vision changes can occur. If you experience any severe reactions, contact your healthcare provider immediately. It's also essential to inform your doctor about all other medications you're taking to avoid adverse interactions. Since ANORO ELLIPTA can cause dizziness or blurred vision in some individuals, exercise caution when driving or operating heavy machinery until you know how the medication affects you. Always prioritize safety and ensure you're following the prescribed treatment plan closely.